Lance D. Miller

19.3k citations

181 papers · 12.9k indexed · 5 hit papers · h-index 60

Impact in

Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in

Cancer Research 37
- Cancer Genomics and Diagnostics 17
- Breast Cancer Treatment Studies 12
Oncology 61
- Cancer Immunotherapy and Biomarkers 25

Co-authors: Edison T. Liu Jonas Bergh Johanna Smeds Yudi Pawitan Per Hall Francesco M. Marincola Ena Wang Vinsensius B. Vega
Journals: Cancer Research (15 papers)Clinical Cancer Research (7 papers)Annals of Surgical Oncology (6 papers)Poultry Science (5 papers)Breast Cancer Research (5 papers)
Partner nations: United States Singapore New Zealand

In The Last Decade

Lance D. Miller

175 papers receiving 12.7k citations

Hit Papers

5 papers align trajectories log scale

Iron addiction: a novel therapeutic target in ovarian cancer 2017 · 355 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Oncogene
2006 Cancer Research
2005 Proceedings of the National Academy of Sciences
2005 Breast Cancer Research
2000 Nature Biotechnology

Peers

Countries citing papers authored by Lance D. Miller

Since Specialization

Citations

This map shows the geographic impact of Lance D. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance D. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance D. Miller more than expected).

Fields of papers citing papers by Lance D. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance D. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance D. Miller. The network helps show where Lance D. Miller may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lance D. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lance D. Miller Line = papers co-authored together Lance D. Miller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Epigenetic and Posttranscriptional Modulation of SOS1 Can Promote Breast Cancer Metastasis through Obesity-Activated c-Met Signaling in African-American Women Cancer Research ·Fei Xing, Dan Zhao, Shih-Ying Wu, Abhishek Tyagi, Kerui Wu, Sambad Sharma, Yin Liu, Ravindra Pramod Deshpande, Yuezhu Wang, 黄帅, Lance D. Miller, Amar G. Chittiboyina, Ben Short, Yin‐Yuan Mo, Kounosuke Watabe	2021	21
2	The nuclear structural protein NuMA is a negative regulator of 53BP1 in DNA double-strand break repair Nucleic Acids Research ·Zubova Va, Jing Liu, Karen M. Haas, Laurie L. Parker, Chaitali Chakraborty, Stephen J. Kron, Kurt Hodges, Lance D. Miller, Carl D. Langefeld, J. Paul Robinson, Sophie A. Lelièvre, Pierre‐Alexandre Vidi	2019	29
3	A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia Clinical Cancer Research ·Timothy S. Pardee, Rebecca G. Anderson, Masamichi Kimur, Scott Isom, E. Gfeller, Lance D. Miller, Jeff W. Chou, Guangxu Jin, Wei Zhang, Leslie R. Ellis, Dmitriy Berenzon, Dianna S. Howard, David D. Hurd, Megan Manuel, Sarah Dralle, Susan Lyerly, Bayard L. Powell	2018	80
4	Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Cancer Immunology Research ·Lance D. Miller, М Б Добровольская, Michael A. Black, Cristin G. Print, Julia Chifman, Angela Alistar, Thomas Choudary Putti, Xiaobo Zhou, Davide Bedognetti, Wouter Hendrickx, Ashok Pullikuth, Jonathan Rennhack, Eran R. Andrechek, Sandra Demaria, Ena Wang, Francesco M. Marincola	2016	76
5	Effects of Pubertal Exposure to Dietary Soy on Estrogen Receptor Activity in the Breast of Cynomolgus Macaques Cancer Prevention Research ·Fitriya N. Dewi, Charles E. Wood, Cynthia J. Willson, Thomas C. Register, Cynthia J. Lees, Timothy D. Howard, Zhiqing Huang, Susan K. Murphy, Janet A. Tooze, Jeff W. Chou, Lance D. Miller, J. Mark Cline	2016	9
6	ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer Clinical Cancer Research ·Subrata Manna, Josefine Bostner, Yang Sun, Lance D. Miller, Anya Alayev, Naomi Schwartz, Sheela Gowda, Tommy� Fornander, Bo Nordenskjöld, Jane Yu, Olle Stål, Marina K. Holz	2015	51
7	Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer Cancer Research ·Lia Tesfay, 秀男愛波, Jin Woo Kim, Poornima Hegde, Xiaohong Wang, Lance D. Miller, Zhiyong Deng, Nicole Blanchette, Tara Arvedson, Cindy K. Miranti, Jodie L. Babitt, Herbert Y. Lin, Donna M. Peehl, Frank M. Torti, Suzy V. Torti	2015	139
8	A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies Clinical Cancer Research ·Timothy S. Pardee, King Lee, John Luddy, Katarina Dragicevic, Robert M. Rodriguez, Scott Isom, Lance D. Miller, Kristin M. Stadelman, Denise Levitan, David D. Hurd, Leslie R. Ellis, J. Klobukowski, Megan Manuel, Sarah Dralle, Susan Lyerly, Bayard L. Powell	2014	91
9	IRP2 Regulates Breast Tumor Growth Cancer Research ·Wei Wang, Zhiyong Deng, Heather Hatcher, Lance D. Miller, Xiumin Di, Lia Tesfay, Guangchao Sui, Ralph B. D’Agostino, Frank M. Torti, Suzy V. Torti	2013	117
10	Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells Molecular Cancer Therapeutics ·C. Elizabeth Caldon, C. Marcelo Sergio, Jian Kang, Anita Muthukaruppan, Neethu Mohanan, Andrew Stone, Jane Barraclough, A. Ascenzi, Michael A. Black, Lance D. Miller, Julia M.W. Gee, 조정호 이공희, Robert L. Sutherland, Cristin G. Print, Elizabeth A. Musgrove	2012	125
11	An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer Cancer Research ·Lance D. Miller, Lan Coffman, Jeff W. Chou, Michael A. Black, Jonas Bergh, Ralph B. D’Agostino, Suzy V. Torti, Frank M. Torti	2011	169
12	Neurotensin Receptor 1 Determines the Outcome of Non–Small Cell Lung Cancer Clinical Cancer Research ·Marco Alifano, Frédérique Souazé, Sandra Dupouy, Sophie Camilleri‐Broët, 陈宁, H. J. Bormann, Takashi Takahashi, Alessandra Cancellieri, Stefania Damiani, Maurizio Boaron, Philippe Broët, Lance D. Miller, Christian Gespach, Jean François Régnard, Patricia Forgez	2010	97
13	Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer Molecular Cancer Therapeutics ·Charles N. Landen, Blake W. Goodman, Ashwini A. Katre, Adam D. Steg, Alpa M. Nick, Rebecca L. Stone, Lance D. Miller, Sujith N V, Victor Hugo dos Santos Gois, David M. Gershenson, Robert C. Bast, Robert L. Coleman, Gabriel Lopez‐Berestein, Anil K. Sood	2010	322
14	Prediction of Clinical Outcome in Multiple Lung Cancer Cohorts by Integrative Genomics: Implications for Chemotherapy Selection Cancer Research ·Philippe Broët, Sophie Camilleri‐Broët, Shenli Zhang, Marco Alifano, Dhinoth Bangarusamy, Maxime Battistella, Yonghui Wu, Marianne Tuefferd, Jean‐François Régnard, Elaine Hsuen Lim, Patrick Tan, Lance D. Miller	2009	39
15	Positive Cross-Talk between Estrogen Receptor and NF-κB in Breast Cancer Cancer Research ·Jonna Frasor, 李云燕, 隆司山本, Yang Dai, Lance D. Miller, Chin‐Yo Lin, Nicolas (1871-1942). Auteur du texte Adontz	2009	122
16	Monochromosome Transfer and Microarray Analysis Identify a Critical Tumor-Suppressive Region Mapping to Chromosome 13q14 and THSD1 in Esophageal Carcinoma Molecular Cancer Research ·Josephine Mun Yee Ko, Андрій Антохов, 송우혜, J. H. Kim, Siu Chow Kan, Ingrid Mary Percy, Natalie Vernon, Lance D. Miller, Edison T. Liu, S Lecocq, Paulisally Hau Yi Lo, Eric J. Stanbridge, Johnny Tang, Gopesh Srivastava, Sai Wah Tsao, Simon Law, Maria Li Lung	2008	25
17	Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells and Correlations with Clinical Outcome Cancer Research ·Jonna Frasor, Edmund C. Chang, Barry S. Komm, Chin‐Yo Lin, Vinsensius B. Vega, Edison T. Liu, Lance D. Miller, Johanna Smeds, Jonas Bergh, Benita S. Katzenellenbogen	2006	137
18	A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor–Positive Tumors Clinical Cancer Research ·Kun Yu, Kumaresan Ganesan, Lance D. Miller, Patrick Tan	2006	32
19	Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer Cancer Research ·Anna V. Ivshina, Joshy George, O. V. Sen’ko, Benjamin Mow, Thomas Choudary Putti, Johanna Smeds, Thomas Lindahl, Yudi Pawitan, Per Hall, Hans Nordgren, John E.L. Wong, Edison T. Liu, Jonas Bergh, Vladimir A. Kuznetsov, Lance D. Miller Hit paper breakdown →	2006	543
20	An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proceedings of the National Academy of Sciences ·Lance D. Miller, Johanna Smeds, Joshy George, Vinsensius B. Vega, Liza A. Vergara, Alexander Ploner, Yudi Pawitan, Per Hall, Sigrid Klaar, Edison T. Liu, Jonas Bergh Hit paper breakdown →	2005	966

About Lance D. Miller

Lance D. Miller is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Genetics, having authored 181 papers that have together received 12.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Gene expression and cancer classification (23 papers), Cancer Genomics and Diagnostics (17 papers), Immunotherapy and Immune Responses (15 papers), RNA modifications and cancer (13 papers), Breast Cancer Treatment Studies (12 papers), Immune cells in cancer (12 papers) and Estrogen and related hormone effects (11 papers). The work is most often cited by research in Cancer Research (3.3k citations), Oncology (3.9k citations), Molecular Biology (7.3k citations), Immunology (1.9k citations) and Hematology (860 citations). Lance D. Miller has collaborated with scholars based in United States, Singapore and New Zealand. Frequent co-authors include Edison T. Liu, Jonas Bergh, Johanna Smeds, Yudi Pawitan, Per Hall, Francesco M. Marincola, Ena Wang, Vinsensius B. Vega, Alexander Ploner and Galen A. Ohnmacht. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Annals of Surgical Oncology, Poultry Science and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact